Literature DB >> 8229319

Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism.

M Ito1, M Kimura, Y Deguchi, A Miyamori-Watabe, T Yajima, T Kan.   

Abstract

The effects of transgalactosylated disaccharide (TD) intake on human fecal microflora and their metabolism were investigated in 12 Japanese males. TD is a mixture of sugars, galactosyl galactose, and galactosyl glucose, synthesized from lactose through the transgalactosylation reaction of Streptococcus thermophilus beta-galactosidase. Volunteers took 15 g of the test sugar daily for 6 days. The TD ingestion increased the number of bifidobacteria and lactobacilli, but decreased the number of Bacteroidaceae and Candida spp. in the feces. The ratio of bifidobacteria to total bacteria increased from 0.28 to 0.51. TD decreased the fecal concentrations of propionic acid, isobutyric acid, isovaleric acid, and valeric acid. This sugar also lowered the fecal pH, and the concentrations of fecal ammonia, p-cresol, and indole. Moreover, a positive correlation was found between the concentration of ammonia, and that of branched-chain fatty acids (isobutyric acid and isovaleric acid), p-cresol, and indole. All of these compounds are produced from amino acids through deamination by the intestinal bacteria. The depression of amino acid fermentation by intestinal bacteria may be involved in the reduction of fecal ammonia. These results suggest that a part of the transgalactosylated disaccharides passes into the colon, inducing changes in the colonic microflora composition, hastening carbohydrate fermentation, and depressing amino acid fermentation in the human gut.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229319     DOI: 10.3177/jnsv.39.279

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  5 in total

Review 1.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.

Authors:  Matthew J Bull; Nigel T Plummer
Journal:  Integr Med (Encinitas)       Date:  2015-02

3.  Effects of young barley leaf powder on gastrointestinal functions in rats and its efficacy-related physicochemical properties.

Authors:  Motoya Ikeguchi; Masahito Tsubata; Akira Takano; Tomoyasu Kamiya; Kinya Takagaki; Hideyuki Ito; Yohko Sugawa-Katayama; Hideaki Tsuji
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-08       Impact factor: 2.629

4.  Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.

Authors:  Megan Rossi; Kerenaftali Klein; David W Johnson; Katrina L Campbell
Journal:  Int J Nephrol       Date:  2012-12-19

5.  SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial.

Authors:  Megan Rossi; David W Johnson; Mark Morrison; Elaine Pascoe; Jeff S Coombes; Josephine M Forbes; Brett C McWhinney; Jacobus P J Ungerer; Goce Dimeski; Katrina L Campbell
Journal:  BMC Nephrol       Date:  2014-07-04       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.